687
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Antitumor activity of polysaccharides isolated from Patrinia heterophylla

, , , , &
Pages 1012-1017 | Received 26 Nov 2008, Accepted 25 Oct 2009, Published online: 23 Aug 2010
 

Abstract

The research investigated the effect of Patrinia heterophylla Bunge (Valerianaceae) polysaccharides (PHB-P1) on U14-bearing mice. The tumor weight of mice treated with PHB-P1 (30, 60 mg/kg body weight) was significantly lower than that of the control group, a decrease of serum lactate dehydrogenase (LDH) activity was observed, and the serum alkaline phosphatase (AKP) level was increased slightly. The number of apoptotic tumor cells was significantly increased in the mice by treatment of PHB-P1 (30, 60 mg/kgbw). Cell cycle analysis showed the accumulation of tumor cells in the G2/M phase and a relative decrease of the S phase. By the immunohistochemical analysis, PHB-P1 (30, 60 mg/kgbw) might up-regulate the expression of p53 and Bax, and significantly inhibited the expression of Bcl-2 in tumor tissues. In conclusion, PHB-P1 could inhibit tumor growth and induce tumor cell apoptosis.

Acknowledgements

The authors would like to thank Zhao Jian-Cheng who authenticated the Patrinia heterophylla samples used. Geng Guo-Xia and Lu Wen-Zong equally contributed to the work.

Declaration of interest

This study was supported by the Science and Technology Development Fund of Science and Technology Investing Company, Qinhuangdao, China (D08).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.